Viewing Study NCT06062420


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-15 @ 1:54 PM
Study NCT ID: NCT06062420
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2023-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
Sponsor:
Organization: